Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics

Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics

With the Catalent transaction anticipated to close in 2Q 2019, the combined strengths of each organization will assure best manufacturing assets and unmatched operational excellence in one of the fastest-growing areas of healthcare BALTIMORE, MD, April 15, 2019 –...